Shu Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shu Yang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Zhigang Zhao
Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University
2 shared publications - Anchen Guo
Laboratory of Clinical Medicine Research, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
1 shared publication Bin Zhu
Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
1 shared publication- Chen Li
State Key Laboratory of Aerodynamics, Sichuan, China
1 shared publication Hong Jin
Institute of Disease Prevention and Control of PLA, Beijing, China
1 shared publicationJinping Hu
Department of Drug Metabolism of Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Institution of Engineering and Technology (IET) in IET Systems Biology
- Vol. 20 (1)
Bioinformatics Analysis to Reveal Potential Targets of Huntington's Disease
Huntington's disease (HD) is a progressive neurodegenerative disease resulted from the expansion of CAG repeats in huntingtin (HTT) gene and characterised by motor impairment, psychiatric disorders and cognitive decline. Currently, there are no available disease‐modifying treatments. In this study, we performed an integrative analysis of HD datasets downloaded from the Gene Expression Omnibus (GEO) database using machine learning approaches, Mendelian randomisation (MR) and single cell RNA‐sequencing (scRNA‐seq) analysis to elucidate underlying disease mechanisms. The machine learning algorithms of LASSO, random forest and SVM‐RFE identified the decreased ADRA2A in HD. In addition, MR analysis revealed HD‐associated proteins such as LILRA4 and UBE2D1, associated with immune response and ubiquitination metabolism, respectively. scRNA‐seq analysis further identified the transcription factors of SOX4 and ETV1 through SCENIC analysis. Pseudotime trajectory analysis highlighted heparan sulphate sulfotransferase activity, involving genes CHST11, HS3ST3A1 and HS6ST3 that drive cell differentiation. Moreover, cell‐cell communication analysis demonstrated enhanced NRG1/3‐ERBB4 signalling pathway in HD. This study presents multiple potential targets for HD treatment but further experimental validation is required to confirm their functional relevance.
- 1 January 2026
- Published by Institution of Engineering and Technology (IET) in IET Systems Biology
- Vol. 20 (1)
Open AccessBioinformatics Analysis to Reveal Potential Targets of Huntington's Disease
Huntington's disease (HD) is a progressive neurodegenerative disease resulted from the expansion of CAG repeats in huntingtin (HTT) gene and characterised by motor impairment, psychiatric disorders and cognitive decline. Currently, there are no available disease‐modifying treatments. In this study, we performed an integrative analysis of HD datasets downloaded from the Gene Expression Omnibus (GEO) database using machine learning approaches, Mendelian randomisation (MR) and single cell RNA‐sequencing (scRNA‐seq) analysis to elucidate underlying disease mechanisms. The machine learning algorithms of LASSO, random forest and SVM‐RFE identified the decreased ADRA2A in HD. In addition, MR analysis revealed HD‐associated proteins such as LILRA4 and UBE2D1, associated with immune response and ubiquitination metabolism, respectively. scRNA‐seq analysis further identified the transcription factors of SOX4 and ETV1 through SCENIC analysis. Pseudotime trajectory analysis highlighted heparan sulphate sulfotransferase activity, involving genes CHST11, HS3ST3A1 and HS6ST3 that drive cell differentiation. Moreover, cell‐cell communication analysis demonstrated enhanced NRG1/3‐ERBB4 signalling pathway in HD. This study presents multiple potential targets for HD treatment but further experimental validation is required to confirm their functional relevance.
- 28 November 2018
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 39 (9) , 431-436
CYP2J2 is the major enzyme in human liver microsomes responsible for hydroxylation of SYL‐927, a novel and selective sphingosine 1‐phosphate receptor 1 (S1P 1 ) agonist
SYL‐927, a novel and selective S1P 1 agonist, is transferred to its active phosphate for the regulation of lymphocyte recirculation. This in vitro metabolism study is to elucidate the P450‐mediated oxidation pathway of SYL‐927 in human liver microsomes (HLMs). The results demonstrated that the ω‐1 hydroxylated metabolite SYL‐927‐M was formed after incubation of SYL‐927 with HLMs. Recombinant human CYP1A1 and CYP2J2 can efficiently catalyse SYL‐927‐M formation, followed by markedly less substrate conversion with CYP1A2, CYP2C19 and CYP2D6. Inhibition studies with chemical inhibitors and antibodies suggested that arachidonic acid, the substrate of CYP2J2, and CYP2J2‐specific antibody effectively inhibited the formation of SYL‐927‐M in HLMs whereas no significant inhibition was observed with the inhibitors for CYP1A1, CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1 and CYP3A4, demonstrating that CYP2J2 was primarily responsible for the formation of SYL‐927‐M.
- 28 November 2018
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 39 (9) , 431-436
CYP2J2 is the major enzyme in human liver microsomes responsible for hydroxylation of SYL‐927, a novel and selective sphingosine 1‐phosphate receptor 1 (S1P 1 ) agonist
SYL‐927, a novel and selective S1P 1 agonist, is transferred to its active phosphate for the regulation of lymphocyte recirculation. This in vitro metabolism study is to elucidate the P450‐mediated oxidation pathway of SYL‐927 in human liver microsomes (HLMs). The results demonstrated that the ω‐1 hydroxylated metabolite SYL‐927‐M was formed after incubation of SYL‐927 with HLMs. Recombinant human CYP1A1 and CYP2J2 can efficiently catalyse SYL‐927‐M formation, followed by markedly less substrate conversion with CYP1A2, CYP2C19 and CYP2D6. Inhibition studies with chemical inhibitors and antibodies suggested that arachidonic acid, the substrate of CYP2J2, and CYP2J2‐specific antibody effectively inhibited the formation of SYL‐927‐M in HLMs whereas no significant inhibition was observed with the inhibitors for CYP1A1, CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1 and CYP3A4, demonstrating that CYP2J2 was primarily responsible for the formation of SYL‐927‐M.
- Open Access
- 23 October 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (10) , e0187017
Identification of two immortalized cell lines, ECV304 and bEnd3, for in vitro permeability studies of blood-brain barrier
To identify suitable cell lines for a mimetic system of in vivo blood-brain barrier (BBB) for drug permeability assessment, we characterized two immortalized cell lines, ECV304 and bEnd3 in the respect of the tightness, tight junction proteins, P-glycoprotein (P-gp) function and discriminative brain penetration. The ECV304 monoculture achieved higher transendothelial electrical resistance (TEER) and lower permeability to Lucifer yellow than bEnd3. However, co-culture with rat glioma C6 cells impaired the integrity of ECV304 and bEnd3 cell layers perhaps due to the heterogeneity among C6 cells in inducing BBB characteristics. The immunostaining of ZO-1 delivered distinct bands along cell borders on both cell lines while those of occludin and claudin-5 were diffused and weak. P-gp functionality was only proved in bEnd3 by Rhodamine 123 (R123) uptake assay. A permeability test of reference compounds displayed a similar rank order (digoxin < R123 < quinidine, verapamil < propranolol) in ECV304 and bEnd3 cells. In comparison with bEnd3, ECV304 developed tighter barrier for the passage of reference compounds and higher discrimination between transcellular and paracellular transport. However, the monoculture models of ECV304 and bEnd3 fail to achieve the sufficient tightness of in vitro BBB permeability models with high TEER and evident immunostaining of tight junction proteins. Further strategies to enhance the paracellular tightness of both cell lines to mimic in vivo BBB tight barrier deserve to be conducted.
- 23 October 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (10) , e0187017
Open AccessIdentification of two immortalized cell lines, ECV304 and bEnd3, for in vitro permeability studies of blood-brain barrier
To identify suitable cell lines for a mimetic system of in vivo blood-brain barrier (BBB) for drug permeability assessment, we characterized two immortalized cell lines, ECV304 and bEnd3 in the respect of the tightness, tight junction proteins, P-glycoprotein (P-gp) function and discriminative brain penetration. The ECV304 monoculture achieved higher transendothelial electrical resistance (TEER) and lower permeability to Lucifer yellow than bEnd3. However, co-culture with rat glioma C6 cells impaired the integrity of ECV304 and bEnd3 cell layers perhaps due to the heterogeneity among C6 cells in inducing BBB characteristics. The immunostaining of ZO-1 delivered distinct bands along cell borders on both cell lines while those of occludin and claudin-5 were diffused and weak. P-gp functionality was only proved in bEnd3 by Rhodamine 123 (R123) uptake assay. A permeability test of reference compounds displayed a similar rank order (digoxin < R123 < quinidine, verapamil < propranolol) in ECV304 and bEnd3 cells. In comparison with bEnd3, ECV304 developed tighter barrier for the passage of reference compounds and higher discrimination between transcellular and paracellular transport. However, the monoculture models of ECV304 and bEnd3 fail to achieve the sufficient tightness of in vitro BBB permeability models with high TEER and evident immunostaining of tight junction proteins. Further strategies to enhance the paracellular tightness of both cell lines to mimic in vivo BBB tight barrier deserve to be conducted.
- 1 October 2009
- Published by Wiley in Journal of Neuroscience Research
- Vol. 87 (13) , 2872-2880
Stereological investigation of age-related changes of myelinated fibers in the rat cortex
In the present study, the cortex volume, total volume, total length and mean diameter of the myelinated fibers in the cortices of young, middle‐aged, and aged Long‐Evans rats were quantitatively investigated by using stereological methods and electron microscopy techniques. There were no significant differences in the myelinated fibers between young and middle‐aged rat cortex. The cortex volume and the total length of the myelinated fibers in the cortex of aged rats were significantly lower than those of young and middle‐aged rats. However, no significant difference was found in the total volume of the myelinated fibers among three groups. The disproportional changes in the total length and total volume of the myelinated fibers in the cortex of aged rats and the absolute distribution of the total length of the myelinated fibers in the cortex of the three groups suggested that the age‐induced decrease of the myelinated fibers might be due mainly to a loss of the myelinated fibers with smaller diameters. The present results together with our previous findings indicated that the age‐related changes of the myelinated fibers occurred widely in the central nervous system and that the age‐related changes of the myelinated fibers in cortex occurred later than those in white matter.
- 1 October 2009
- Published by Wiley in Journal of Neuroscience Research
- Vol. 87 (13) , 2872-2880
Stereological investigation of age-related changes of myelinated fibers in the rat cortex
In the present study, the cortex volume, total volume, total length and mean diameter of the myelinated fibers in the cortices of young, middle‐aged, and aged Long‐Evans rats were quantitatively investigated by using stereological methods and electron microscopy techniques. There were no significant differences in the myelinated fibers between young and middle‐aged rat cortex. The cortex volume and the total length of the myelinated fibers in the cortex of aged rats were significantly lower than those of young and middle‐aged rats. However, no significant difference was found in the total volume of the myelinated fibers among three groups. The disproportional changes in the total length and total volume of the myelinated fibers in the cortex of aged rats and the absolute distribution of the total length of the myelinated fibers in the cortex of the three groups suggested that the age‐induced decrease of the myelinated fibers might be due mainly to a loss of the myelinated fibers with smaller diameters. The present results together with our previous findings indicated that the age‐related changes of the myelinated fibers occurred widely in the central nervous system and that the age‐related changes of the myelinated fibers in cortex occurred later than those in white matter.